Adjunctive ziprasidone improves response in escitalopram‐resistant depression

The atypical antipsychotic ziprasidone had greater antidepressant efficacy compared with placebo when added to escitalopram therapy in individuals with persistent symptoms after 8 weeks of escitalopram alone, a new study has found. Patients receiving ziprasidone plus escitalopram also showed improvement on anxiety measures, according to the study. Results were published online June 18 in the American Journal of Psychiatry.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Adjunctive Therapy Source Type: research